Abstract
Purpose: Comparative genomic hybridization (CGH) is a powerful DNA-based cytogenetic technique that allows the entire genome to be scanned for chromosomal imbalances without requiring the sample material to be mitotically active. During the past 2 years we received many requests from various medical centers around the country to use CGH to resolve the identity of aberrant chromosomal material.
Methods: We report the use of CGH for the evaluation of 12 clinical postnatal cases in which traditional cytogenetic analysis yielded ambiguous results. This series consisted of five marker chromosomes, five unbalanced translocations, and two intrachromosomal duplications.
Results: Identification and characterization of the additional unknown chromosomal material was achieved with use of CGH. All CGH findings were validated by traditional fluorescence in situ hybridization and other specialized staining techniques.
Conclusions: These results demonstrate the effective use of CGH as a focused, single-step method for the identification of chromosomal material of unknown origin.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Levy, B., Dunn, T., Kaffe, S. et al. Clinical applications of comparative genomic hybridization. Genet Med 1, 4–12 (1998). https://doi.org/10.1097/00125817-199811000-00004
Issue Date:
DOI: https://doi.org/10.1097/00125817-199811000-00004
Keywords
This article is cited by
-
Noninvasive prenatal diagnosis targeting fetal nucleated red blood cells
Journal of Nanobiotechnology (2022)
-
From microscopes to microarrays: dissecting recurrent chromosomal rearrangements
Nature Reviews Genetics (2007)